Product NDC: | 62856-797 |
Proprietary Name: | Aloxi |
Non Proprietary Name: | palonosetron hydrochloride |
Active Ingredient(s): | .25 mg/5mL & nbsp; palonosetron hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62856-797 |
Labeler Name: | Eisai, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021372 |
Marketing Category: | NDA |
Start Marketing Date: | 20030725 |
Package NDC: | 62856-797-01 |
Package Description: | 1 VIAL in 1 CARTON (62856-797-01) > 5 mL in 1 VIAL |
NDC Code | 62856-797-01 |
Proprietary Name | Aloxi |
Package Description | 1 VIAL in 1 CARTON (62856-797-01) > 5 mL in 1 VIAL |
Product NDC | 62856-797 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | palonosetron hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20030725 |
Marketing Category Name | NDA |
Labeler Name | Eisai, Inc |
Substance Name | PALONOSETRON HYDROCHLORIDE |
Strength Number | .25 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |